Martina Schmidt Selected Research

diethylstilbestrol monophosphate (PDES)

1/2020	Phosphodiesterase isoforms and cAMP compartments in the development of new therapies for obstructive pulmonary diseases.
1/2019	Phosphodiesterases as therapeutic targets for respiratory diseases.
1/2018	Cigarette smoke up-regulates PDE3 and PDE4 to decrease cAMP in airway cells.
2/2013	Distinct PKA and Epac compartmentalization in airway function and plasticity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martina Schmidt Research Topics

Disease

17	Chronic Obstructive Pulmonary Disease (COPD) 07/2022 - 06/2011
10	Inflammation (Inflammations) 12/2020 - 10/2005
10	Neoplasms (Cancer) 01/2020 - 03/2003
6	Lung Diseases (Lung Disease) 01/2022 - 09/2009
5	Asthma (Bronchial Asthma) 01/2020 - 10/2008
5	Neuroblastoma 01/2020 - 08/2004
4	Airway Remodeling 09/2017 - 10/2011
3	Mitochondrial Diseases (Mitochondrial Disease) 11/2021 - 01/2020
3	Pneumonia (Pneumonitis) 12/2020 - 01/2016
3	Hypertrophy 02/2018 - 04/2007
3	Disease Progression 01/2016 - 03/2004
3	Multiple Sclerosis 10/2005 - 02/2003
2	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 01/2019
2	Diabetic Retinopathy (Retinopathy, Diabetic) 12/2021 - 05/2020
2	Necrosis 11/2021 - 01/2021
2	Chemical and Drug Induced Liver Injury 11/2021 - 01/2021
2	Fibrosis (Cirrhosis) 01/2020 - 03/2006
2	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2020 - 02/2013
2	Liver Diseases (Liver Disease) 01/2019 - 12/2013
2	Hypoxia (Hypoxemia) 01/2018 - 04/2011
2	Hypothermia 01/2012 - 01/2011
2	Breast Neoplasms (Breast Cancer) 12/2009 - 08/2009
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2005 - 03/2004
2	Leukemia 03/2004 - 03/2003
1	Amyloidosis 11/2022
1	Pathologic Processes 01/2022
1	Osteoarthritis 12/2021
1	Body Weight (Weight, Body) 12/2021
1	Pain (Aches) 11/2021
1	Respiratory Hypersensitivity 01/2021
1	Lung Injury 12/2020
1	Hyperglycemia 10/2020
1	Chronic Bronchitis 01/2020
1	Idiopathic Pulmonary Fibrosis 01/2020
1	Glioma (Gliomas) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2020

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2018 - 03/2003
11	erythromycin propionate-N-acetylcysteinateIBA 11/2021 - 04/2007
9	SmokeIBA 01/2022 - 06/2011
8	Cyclic AMP (AMP, Cyclic)IBA 01/2018 - 08/2004
5	Pharmaceutical PreparationsIBA 01/2022 - 01/2019
4	Dinoprostone (PGE2)FDA Link 01/2022 - 01/2015
4	Cholinergic Antagonists (Anticholinergics)IBA 01/2021 - 01/2016
4	diethylstilbestrol monophosphate (PDES)IBA 01/2020 - 02/2013
4	CytokinesIBA 11/2012 - 03/2003
3	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 07/2022 - 01/2020
3	Caspase 3 (Caspase-3)IBA 11/2021 - 01/2012
3	Phosphodiesterase 4 InhibitorsIBA 01/2020 - 09/2017
3	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2020 - 02/2013
3	Adenosine Monophosphate (AMP)IBA 01/2020 - 01/2015
3	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2019 - 06/2014
3	CateninsIBA 01/2018 - 01/2015
3	CalciumIBA 01/2018 - 04/2007
3	GTP Phosphohydrolases (GTPases)IBA 10/2008 - 11/2004
2	Vehicle Emissions (Emissions, Vehicle)IBA 07/2022 - 12/2020
2	Air Pollutants (Pollutants, Air)IBA 01/2022 - 12/2020
2	HexosaminesIBA 12/2021 - 10/2020
2	Diclofenac (SR 38)FDA LinkGeneric 11/2021 - 01/2021
2	SYTOX GreenIBA 11/2021 - 01/2021
2	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2021 - 09/2017
2	NM23 Nucleoside Diphosphate KinasesIBA 10/2020 - 05/2020
2	Protein Isoforms (Isoforms)IBA 01/2020 - 03/2004
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 01/2011
2	GoldIBA 01/2020 - 04/2015
2	RoflumilastIBA 01/2020 - 01/2019
2	Messenger RNA (mRNA)IBA 04/2015 - 03/2003
2	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2015 - 08/2004
2	LigandsIBA 01/2015 - 10/2005
2	ColforsinIBA 01/2015 - 08/2004
2	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2013 - 07/2007
2	Phosphotransferases (Kinase)IBA 02/2013 - 06/2011
2	Hormones (Hormone)IBA 01/2013 - 08/2009
2	Serotonin (5 Hydroxytryptamine)IBA 01/2012 - 01/2011
2	Interleukin-8 (Interleukin 8)IBA 01/2012 - 09/2009
2	Transcription Factors (Transcription Factor)IBA 06/2011 - 10/2005
2	rho-Associated KinasesIBA 01/2011 - 03/2006
2	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 04/2007 - 11/2004
2	PPAR-gamma AgonistsIBA 10/2005 - 03/2004
2	Pioglitazone (Actos)FDA Link 10/2005 - 03/2004
2	PPAR gammaIBA 10/2005 - 03/2004
1	Prealbumin (Transthyretin)IBA 11/2022
1	patisiranIBA 11/2022
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Glucosamine (Dona)IBA 12/2021
1	Blood Glucose (Blood Sugar)IBA 12/2021
1	Metformin (Glucophage)FDA LinkGeneric 11/2021
1	Bronchodilator Agents (Bronchodilators)IBA 01/2021
1	indacaterolIBA 01/2021
1	Cholinergic Agents (Cholinergics)IBA 01/2021
1	Dimethyl FumarateIBA 12/2020
1	Fossil Fuels (Fossil Fuel)IBA 12/2020
1	Retinaldehyde (Retinal)IBA 10/2020
1	Angiopoietin-2IBA 10/2020
1	Oxidoreductases (Dehydrogenase)IBA 01/2020

Therapy/Procedure

14	Therapeutics 11/2022 - 08/2009
2	Liver Transplantation 11/2022 - 01/2019
2	Rewarming 04/2011 - 01/2011
2	Oral Administration 10/2005 - 03/2004
1	Transplantation 11/2022